Tiny worms could be key to solving Type 1 diabetes and other autoimmune ailments
There is a new weapon in the fight against autoimmune diseases such as Type 1 diabetes, rheumatoid arthritis, Crohn’s disease and lupus, the common trait of which is an immune system that attacks its own organs and tissues.
William Gause, an immunologist at Rutgers New Jersey Medical School, is among those leading the charge against these diseases by studying how the human body reacts to worms. The worms Gause studies, or helminths as biologists call them, are small parasites that live in human intestines, especially in the developing world.
According to an article in Nature Reviews Immunology by Gause and colleagues from the National Institutes of Health and the University of Edinburgh, the worms’ presence through millennia of human evolution likely has led to an immune response called type 2 immunity. This includes immune regulatory pathways that help control the inflammation that can contribute to autoimmune diseases.
The immune reaction, the researchers say, appears to have developed as a way to rapidly repair wounds caused by these invaders as they move through the body. In fact, components of the type 2 immune response may someday be used to enhance the wound healing process. Additionally, this response triggers regulatory networks that block harmful immune responses, or inflammation, that otherwise would exacerbate the tissue injury.
“What we would like to do now is harness components of the type 2 immune response to target the control of harmful inflammation that can lead to autoimmune diseases like diabetes and inflammatory bowel disease,” Gause says. He adds that inflammatory responses also have been linked to other diseases, including cardiovascular disease and metabolic disorders, and even to allergic reactions and fibrosis that may result when titanium shavings that flake away from artificial joints settle in the body. “Finding new ways to stimulate these regulatory components of the type 2 immune response may provide us with a new set of tools to target the control of harmful inflammatory responses now associated with this wide array of different diseases.”
For now, live helminths or helminth byproducts may be introduced into the body on a short-term basis to train compromised immune systems. A 2012 study by a Gause-led team found that the introduction of helminths for two weeks caused the immune systems of mice to produce cytokines, or signaling molecules, which gave them lasting protection against Type 1 diabetes.
That finding mirrors human experience in the developing world where helminth infection is endemic, but the incidence of autoimmune diseases such as Type 1 diabetes is extremely low.
“There is a growing body of evidence to support the hygiene hypothesis, which suggests that decreased exposure to microbes and helminths in industrialized countries may impair the development of immune regulatory networks that would otherwise control harmful inflammatory responses,” Gause says.
The Latest on: Parasites as Potential Disease Fighters
- FibroGen Announces Approval of Roxadustat in China for the Treatment of Anemia in Chronic Kidney Disease Patients on Dialysis on December 17, 2018 at 3:34 pm
The adverse events observed were consistent with underlying diseases in patients with CKD ... candidates pamrevlumab and roxadustat, the potential safety and efficacy profile of our product ... […]
- Antarctic penguins in danger from human diseases, researchers say on December 17, 2018 at 11:25 am
These revelations about the potential impact of tourism in Antarctica add to growing concern over visitor numbers in other parts of the world. The Galápagos Islands off the coast of Ecuador are arguab... […]
- Researchers Zero in on Potential Therapeutic Target for Diabetes, Associated Diseases on December 17, 2018 at 11:08 am
“This suggests glucagon-mediated HGP could be a significant potential therapeutic intervention for the control and possible prevention of diabetes.&rdquo […]
- Global Infectious Disease Therapeutics Market 2019-2023 | Development of Novel Drugs to Boost Demand | Technavio on December 17, 2018 at 7:20 am
(Graphic: Business Wire) A key factor driving the growth of the global infectious disease therapeutics market is the growing awareness of infectious diseases ... trend as a major factor that has the p... […]
- Neurotrope Announces Publication of Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease in the Journal of Alzheimer's Disease on December 17, 2018 at 6:17 am
Neurotrope is at the forefront of developing a new approach to combating AD and other neurodegenerative diseases. The Company's world-class science offers the potential to realize a paradigm shift to ... […]
- Pyramid Biosciences Announces Exclusive Global License of AstraZeneca TRK Program for Dermatology and Inflammatory Diseases on December 17, 2018 at 4:18 am
"Through the agreement, Pyramid Biosciences will investigate the molecule as a potential new treatment option for patients with debilitating dermatological diseases." Skin disease is one of the ... […]
- Seer Debuts with Proprietary Proteomics Platform to Enable Early Detection of Cancer and Neurological Diseases on December 17, 2018 at 3:00 am
Seer, Inc., launched today to capture and translate molecular insights from the proteome to enable early detection of cancer and neurological diseases and drive earlier ... technology and novel approa... […]
- A Parasitic Disease Spread by Sandflies Is More Common in the U.S. Than Previously Thought on July 25, 2018 at 12:32 pm
And thanks to climate change, the parasitic illness may become even more common ... so it’s possible that doctors in these endemic areas are simply failing to catch the disease. And the potential rang... […]
- Proteins to Fight Diseases on September 3, 2014 at 7:56 am
Researchers are currently studying blob-like proteins in an effort to determine if they will be able to fight diseases. The structures of the ... work in many different ways rather than as a limited p... […]
- Turning to parasites as potential disease fighters on September 9, 2013 at 6:16 am
The intestinal tracts of many people in the developing world are home to tiny parasites that may point the way toward new treatments for diseases such as Type 1 diabetes. Credit: Shutterstock (Medical ... […]
via Google News and Bing News